HOME >> BIOLOGY >> NEWS
Enzyme action creates protein linked to Alzheimer's disease

DALLAS Aug. 11, 2005 Researchers at UT Southwestern Medical Center have defined a key step in the production of beta-amyloid, a short protein that is thought to be responsible for the development of Alzheimer's disease. Understanding this step may aid in the discovery of drugs that could help block the disease from developing.

In Alzheimer's disease, too much beta-amyloid is produced by an enzyme that has many other essential roles. As a result, simply blocking the whole enzyme knocks out many of its other functions which is fatal to the organism.

Using cultured human and mouse cells, as well as test-tube assays, UT Southwestern researchers singled out how just one portion of the enzyme, a protein called nicastrin, is involved in the pathway that produces beta-amyloid, thereby leading to Alzheimer's disease. They hope next to work on ways to specifically block nicastrin. The study appears in the August 12 issue of the journal Cell.

"The work provides an attractive potential strategy for developing treatment for Alzheimer's disease," said Dr. Gang Yu, assistant professor in the Center for Basic Neuroscience and of cell biology and senior author of the study. The research uncovered an "unprecedented mechanism of biochemistry," Dr. Yu said.

Nicastrin is a large protein that is a component of an enzyme called gamma-secretase, which is lodged in the cell's membrane. When it is at the cell surface, nicastrin sticks out into the area outside the cell. It has been thought to play a key role in the creation of a protein called amyloid-beta the prime suspect for the damage Alzheimer's does to the brain but the exact mechanism was unknown.

Dr. Yu and his colleagues found that nicastrin binds to several proteins lodged in the cell's membrane, including one called amyloid precursor protein, or APP. Nicastrin then guides membrane-bound proteins to the active area of gamma-secretase, which then splits the proteins. APP, for example, is chopped into
'"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
11-Aug-2005


Page: 1 2

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. Enzyme delivered in smaller package protects cells from radiation damage
3. Enzyme Engineering XIX
4. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
5. Enzyme shreds Alzheimers protein
6. Enzyme defect leads to hyperinsulinism
7. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
8. Enzyme crystal structure reveals unexpected genome repair functions
9. Enzyme inhibitors block replication of SARS virus
10. Enzyme may be target for new anti-inflammatory compounds
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 13, 2018 , ... Kenall has enhanced the popular MedMaster MAEC ... These redesigned linear overbed luminaires are equipped with symmetric ambient and asymmetric exam modes, ... dust. , Intended to be specified in pairs, the MAEC is 8” x 48” ...
(Date:11/7/2018)... SAN FRANCISCO (PRWEB) , ... November 07, 2018 ... ... addition of Dr. Catherine Lozupone, PhD, faculty of the Computational Biosciences Program within ... Joining the board of leading scientists and doctors from around the world, Dr. ...
(Date:11/7/2018)... ... 2018 , ... Cognition® Corporation , a software company ... paper discussing Critical-to-Quality (CTQ) Flowup . , The new white paper reviews ... requirements and overall product quality. As a bottom-up methodology, CTQ Flowup allows teams ...
Breaking Biology News(10 mins):
(Date:10/24/2018)... (PRWEB) , ... October 22, 2018 , ... ... today announces the company’s Lunula Laser was featured on an episode of ... , Board-certified dermatologist, Dr. Glynis R. Ablon, MD , discusses and demonstrates ...
(Date:10/24/2018)... (PRWEB) , ... October 23, 2018 , ... ... technologies, today announced a new, exciting brand for its recently created biologics solutions ... Molecular Devices’ Biologics Biotherapeutics portfolio of products, and henceforth will be known as ...
(Date:10/18/2018)... ... ... With rapid technological advances in the fertility field, increasing numbers of women are ... cancer diagnosis requiring chemotherapy or removal of an ovary, most women who freeze their ... not want to get pregnant now but may want to in the future. ...
(Date:10/17/2018)... , ... October 17, 2018 , ... ... and Phytophthora spp. have been validated by USDA’s Animal and Plant Health Inspection ... can use the assays with confidence and trust, knowing they will be able ...
Breaking Biology Technology:
Cached News: